Clive Brown
Chief Tech/Sci/R&D Officer presso OXFORD NANOPORE TECHNOLOGIES PLC
Patrimonio netto: 3 M $ in data 31/03/2024
Profilo
Clive G. Brown occupa la posizione di Chief Technology Officer & Director presso Oxford Nanopore Technologies Plc. In passato il sig. Brown ha occupato la posizione di Direttore-Information Technology presso Solexa Ltd., Principale presso Oxford GlycoSciences Plc, Consulente presso Wellcome Trust Sanger Institute e Consulente presso Glaxo Wellcome, Inc. Clive G. Brown si è laureato presso l'Università di York.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 11/01/2024 | 1 720 213 ( 0.20% ) | 3 M $ | 31/03/2024 |
Posizioni attive di Clive Brown
| Società | Posizione | Inizio |
|---|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Chief Tech/Sci/R&D Officer | 01/07/2008 |
Precedenti posizioni note di Clive Brown
| Società | Posizione | Fine |
|---|---|---|
| The SCO Group Ltd. | Director/Board Member | - |
| Glaxo Wellcome, Inc. | Corporate Officer/Principal | - |
Oxford GlycoSciences Plc
 Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Corporate Officer/Principal | - |
Solexa Ltd.
 Solexa Ltd. Medical SpecialtiesHealth Technology Solexa Ltd. was a developer of instruments for analyzing genes in the process of drug development. It's research methods have included DNA sequencing, gene expression, genotyping and micro-RNA analysis to allow scientists to analyze individual genomes for drug development and personalized medicine. The company was headquartered in Saffron Walden, UK. | Chief Tech/Sci/R&D Officer | - |
Wellcome Trust Sanger Institute
 Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Formazione di Clive Brown
| The University of York | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Technology |
| Aziende private | 5 |
|---|---|
Oxford GlycoSciences Plc
Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Health Technology |
Solexa Ltd.
Solexa Ltd. Medical SpecialtiesHealth Technology Solexa Ltd. was a developer of instruments for analyzing genes in the process of drug development. It's research methods have included DNA sequencing, gene expression, genotyping and micro-RNA analysis to allow scientists to analyze individual genomes for drug development and personalized medicine. The company was headquartered in Saffron Walden, UK. | Health Technology |
Wellcome Trust Sanger Institute
Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Glaxo Wellcome, Inc. | Health Technology |
| The SCO Group Ltd. |
- Borsa valori
- Insiders
- Clive Brown
